speaker-photo

Dr. Ahmed Alshehri

panellist

Consultant Medical Oncologist- KAMC
Assistant Professor of Internal Medicine and Medical Oncology- KSAU - Jeddah

09:45 –10:30

Friday 3-5-2024 Day 1

Role of anthracyclines in early breast cancer

  • When to omit anthracyclines in(neo) adjuvant therapy of HER2-negative breast cancer

    When to use anthracyclines in (neo) adjuvant therapy of HER2-positive breast cancer

Moderator:Dr. Meteeb Alfohaidi

Panel: